Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
SPOTLIGHT: CDC halts Hib boosters after Merck recall
In the wake of Merck's Hib vaccine recall, the CDC is telling docs to stop giving the booster shot that comes due for infants at 12 to 15 months. Sanofi Pasteur won't be able to make up the shortfall, at least not immediately, officials say; Merck recalled 1.2 million doses and shut down production, with new shipments delayed probably until the fourth quarter of 2008. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
